Update on Myositis Therapy: From Today's Standards to Tomorrow's Possibilities

Area of Science:

• Immunology
• Neurology
• Muscle Biology

Background:

• Inflammatory myopathies (myositis) are a group of heterogeneous autoimmune disorders characterized by skeletal muscle inflammation.
• Muscle weakness in the limbs is a primary clinical manifestation.
• Recent research has significantly advanced the understanding of myositis pathogenesis.

Purpose of the Study:

• To review current understanding of myositis pathogenesis, including immune and non-immune mechanisms.
• To discuss established pharmacological treatments for myositis.
• To provide an outlook on emerging therapeutic strategies and future treatment approaches.

Main Methods:

• Review of recent scientific literature on inflammatory myopathies.
• Analysis of innate and adaptive immune response pathways in myositis.
• Discussion of non-inflammatory mechanisms like cellular stress and autophagy.

Main Results:

• New insights into the complex immune pathways involved in myositis development.
• Recognition of the role of non-inflammatory factors, such as cellular stress and impaired autophagy.
• Development of novel, targeted therapies currently under investigation in clinical trials.

Conclusions:

• Understanding of myositis pathogenesis has evolved, incorporating both immune and non-immune mechanisms.
• Novel targeted therapies hold promise for improved treatment outcomes in myositis.
• Future research directions focus on refining treatment strategies based on a deeper mechanistic understanding.